AG10 oral tablet
AG10-001
Phase 1 small_molecule completed
Quick answer
AG10 oral tablet for Amyloid Cardiomyopathy, Transthyretin-Related is a Phase 1 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BridgeBio Oncology Therapeutics
- Indication
- Amyloid Cardiomyopathy, Transthyretin-Related
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed